Public announcement
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
Members of the EQIPD consortium have identified and published 5 Domains for increasing rigour in animal experiments. The 5 Domains are published in Nature Methods and very well supplement the concept of the EQIPD quality system. Read about the EQIPD QS in our eLife publication The domains are summarised below and a more detailed overview…
The EQIPD project was highlighted in a recent publication by DDNews and will be featured at this year’s ECNP ‘campfire sessions’, the ‘Handbook on Good Research Practice in Non-Clinical Pharmacology and Biomedicine’ about quality in preclinical research has just been published, and the Global Preclinical Data Forum (GPDF) is giving out an award on the…
Our book on quality in preclinical research, including many articles from authors within the EQIPD consortium, has just been published: Bespalov A, Michel MC, Steckler T (eds) Handbook of Experimental Pharmacology – Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer Open, Cham, Switzerland. ISBN 978-3-030-33655-4, eBook ISBN 978-3-030-33656-1 (2020). Access the book HERE.
The EQIPD Quality System is the result of a collaborative effort between several people and organizations, yet cannot specifically address all potential scenarios under which research rigor measures are needed and will be implemented. The foundation laid by EQIPD is formulated in the “core requirements” (see link below) and we welcome further efforts to support…
The need for quality standards in preclinical research is gaining attention, especially in translational research. The IMI-PainCare consortium has reached out to EQIPD to collaborate in assessing the study design and data analysis for their studies in the BioPain and TRiPP groups. This collaboration will ensure equivalent quality standards in preclinical research among their project…
EQIPD and our efforts to ” Unclog pipeline for new medicines” is mentioned in form of a brief article in NATURE CORRESPONDENCE. Click here to get to the article!